• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

TetraLogic Pharmaceuticals Corp

+ Add to Watchlist

TLOG:US

6.2800 USD 0.0800 1.26%

As of 20:10:00 ET on 04/17/2014.

Snapshot for TetraLogic Pharmaceuticals Corp (TLOG)

Open: 6.3500 Day's Range: 6.2000 - 6.8280 Volume: 63,365
Previous Close: 6.3600 52wk Range: 5.8900 - 14.7500 1-Yr Rtn: -

Stock Chart for TLOG

No chart data available.
  • TLOG:US 6.2800
  • 1D
  • 1M
  • 1Y
6.3600
Interactive TLOG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TLOG

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2013) -1.0800
Est. PEG Ratio -
Market Cap (M USD) 139.91
Shares Outstanding (M) 22.28
30 Day Average Volume 148,971
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TLOG

No data available

Company Profile & Key Executives for TLOG

TetraLogic Pharmaceuticals Corp operates as a biopharmaceutical company. The Company discovers and develops small molecule peptide-mimetic drugs for the treatment of cancers. TetraLogic offers its products throughout the United States.

J Kevin Buchi "Kevin"President/CEOPete A MeyersCFO/Treasurer
Lesley Russell CooperCOO/Chief Medical OfficerC Glenn BegleySenior VP:Research & Dev
More Company Profile & Key Executives for TLOG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil